Sharps Technology Reports 2025 Year-End Results and Highlights Continued Execution of Solana Treasury Strategy
Rhea-AI Summary
Sharps Technology (NASDAQ:STSS) reported 2025 year-end results highlighting a strategic shift to a Solana-based digital asset treasury. The company holds over 2 million SOL (≈95% staked at ~7% gross yield), reported $269.1M total assets (up from $7.3M), and raised over $430M in FY2025.
Revenue totaled ≈$7.0M (≈$6.8M staking revenue; $204k product revenue). Stockholders’ equity rose to $264.4M, liabilities fell to $4.7M, and legacy manufacturing was phased out to focus on staking, institutional partnerships, and capital deployment.
Positive
- Total assets increased to $269.1M from $7.3M year-end 2024
- Stockholders’ equity grew to $264.4M from $2.0M year-end 2024
- Accumulated over 2 million SOL with ~95% actively staked
- Raised over $430M in capital during FY2025
Negative
- FY2025 revenue of $7.0M was almost entirely staking-derived ($6.8M), with only $204k product revenue
- Balance sheet concentration: $250.1M in digital assets (~93% of total assets)
- Major capital raises via equity and warrant exercises may have dilution implications for shareholders
News Market Reaction – STSS
On the day this news was published, STSS declined 1.32%, reflecting a mild negative market reaction. Argus tracked a peak move of +4.4% during that session. Argus tracked a trough of -2.5% from its starting point during tracking. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $828K from the company's valuation, bringing the market cap to $61.86M at that time. Trading volume was above average at 1.8x the daily average, suggesting increased trading activity.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
STSS was down 7.36% while key medical instrument peers like OSUR, STXS, INFU, NYXH, and UTMD rose between 1.77% and 10.56%, pointing to stock-specific dynamics rather than a sector-wide move.
Previous Crypto Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 05 | Crypto partnership | Positive | -15.2% | BitGo collaboration to institutionalize Solana treasury custody and staking. |
| Jan 26 | Staking income update | Positive | -1.8% | Reported ~7% gross APY and nearly all SOL holdings staked. |
| Jan 12 | Validator launch | Positive | +7.4% | Launched Coinbase-operated STSS Validator with >2M SOL delegated. |
| Oct 09 | Treasury expansion | Positive | +0.5% | Expanded SOL treasury with Coinbase Prime custody and OTC support. |
| Sep 29 | Crypto.com partnership | Positive | +2.7% | Crypto.com partnership to manage >2M SOL and deploy into Solana projects. |
Crypto-treasury headlines have produced mixed reactions, with 3 aligned moves and 2 divergences in the last five crypto-tagged events.
Over the past several months, STSS has repeatedly highlighted its Solana-focused digital asset strategy, including partnerships with Coinbase, Crypto.com, and BitGo and accumulation of over 2 million SOL. Prior crypto-tagged releases often emphasized custody, validator launches, and staking yields. Price reactions have been uneven, with notable moves of -15.18% and +7.41%. Today’s year-end results extend that narrative by quantifying 2025 revenue and balance sheet repositioning around the SOL treasury.
Historical Comparison
In the last five crypto-focused releases, average 24h move was -1.3% with mixed reactions. This year-end crypto-treasury update fits the ongoing shift toward Solana-driven balance sheet transformation.
Crypto-tagged news shows progression from initial SOL accumulation and custody partnerships toward institutional validators, staking income, and now full-year financials dominated by Solana treasury activity.
Regulatory & Risk Context
An effective S-3 shelf dated Oct 23, 2025 registers resale of private-placement and warrant shares. The company is not selling shares under this prospectus but could receive up to $614,837,807.75 in gross proceeds if all registered warrants are exercised. As of the latest data, 0 usage events are recorded.
Market Pulse Summary
This announcement underscores Sharps’ full pivot from legacy manufacturing toward a Solana-centric balance sheet, with total assets of $269.1 million, digital assets of $250.1 million, and net staking revenue of $6.8 million in 2025. Historical crypto-tagged news shows uneven market responses, so investors may track how recurring yields near 7%, over 2 million SOL held, and the existing S-3 warrant registration with up to $614,837,807.75 in potential proceeds interact with future strategic announcements and execution.
Key Terms
staking technical
validator technical
digital asset treasury technical
stablecoin financial
Solana ecosystem technical
OTC trading financial
AI-generated analysis. Not financial advice.
- Over 2 Million SOL Held with Approximately
95% Staked at ~7% Gross Annualized Yield - Total Assets of
$269.1 Million , Up from$7.3 Million at Year-End 2024 - Expanded Solana Ecosystem Partnerships Including Coinbase, Crypto.com, BitGo, and Jupiter
NEW YORK, April 06, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (“Sharps” or the “Company”), a medical device sales and distribution company that has adopted a Solana-based digital asset treasury strategy, has announced financial results for the year ended December 31, 2025, and provided an update on the continued execution of its treasury and infrastructure strategy.
The Company entered 2025 as a capital-constrained medical device manufacturer and exited 2025 with what management believes is the strongest financial and strategic platform in the Company’s history. In a matter of months, Sharps launched a Solana-focused digital asset treasury strategy, accumulated more than 2 million SOL, established a recurring staking income stream with ~
“Our 2025 year-end results reflect a pivotal transition for Sharps Technology,” said Paul K. Danner, Executive Chairman. “During the year, we transformed the Company’s balance sheet, completed our strategic shift away from unprofitable legacy operating activities, established a treasury position of more than 2 million SOL, and laid the foundation for a more scalable and capital-efficient platform. As we move through 2026, we intend to build on a foundation that simply didn’t exist a year ago to grow the Company’s business.”
With legacy manufacturing activities being phased out and a sizable SOL treasury now in place, Sharps believes it is operating from a position of substantially greater strength than a year ago. The Company is focused on maximizing staking economics across its treasury, leveraging institutional-grade counterparties and infrastructure, and deploying its balance sheet in ways management believes can accelerate long-term value creation.
Key highlights from 2025 and recent developments:
- As of December 31, 2025, the Company held over 2 million SOL with approximately
95% actively staked. - The Company had total revenue of approximately
$7.0 million for FY 2025, including$6.8 million in net staking revenue, which represented an approximately7% gross annualized validator staking yield, and$204,120 in product revenue from medical device distribution. - The Company exited FY 2025 with total assets of
$269.1 million (up from$7.3 million at year-end 2024), including$250.1 million in digital assets at fair value,$10.4 million in cash, and positive working capital of$14.2 million . Stockholders’ equity grew to$264.4 million (from$2.0 million at year-end 2024), while total liabilities declined to$4.7 million . The notes payable balance of$3.8 million at year-end 2024 was fully eliminated. - The Company launched its Sharps-branded validator through Coinbase’s institutional infrastructure and expanded strategic partnerships across the Solana ecosystem, including collaborations with Crypto.com, BitGo, Jupiter Exchange, The Tie, Bonk, and Pudgy Penguins.
- The Company raised over
$430 million in total capital during FY 2025 through equity offerings and warrant exercises, including cash, digital asset, and stablecoin contributions, funding the Company’s rapid SOL accumulation and treasury buildout.
Sharps enters 2026 as a materially reshaped company with a strengthened balance sheet, a productive digital asset treasury, a leaner operating profile, and expanded institutional relevance within the Solana ecosystem. Management believes the Company is now positioned not only to benefit from effective treasury execution, but also to leverage that foundation in support of broader strategic initiatives intended to enhance the Company’s long-term growth profile and open additional opportunities for future revenue generation. The Company’s focus in 2026 is to convert its stronger platform into sustained yield generation, disciplined capital deployment, and the measured development of collaborative business capabilities that can support its next stage of growth.
For more detailed information, please refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission on March 31, 2026.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements in this release other than statements of historical fact are forward-looking statements, including statements regarding the Company's execution of its Solana digital asset treasury strategy and the potential opportunities such initiatives may create for retail and institutional audiences. Forward-looking statements are based on current expectations, assumptions, and beliefs, and involve risks and uncertainties that could cause actual results to differ materially.
These risks and uncertainties include, among others: the Company's ability to successfully execute its Solana treasury strategy; volatility in the market price of SOL and other digital assets; changes in the regulatory or legal environments; competitive pressures; and general market, economic, and business conditions. Additional risks are described in the "Risk Factors" section of the Company's filings with the U.S. Securities and Exchange Commission (the "SEC"), which are available on the SEC's website at www.sec.gov.
Forward-looking statements speak only as of the date of this press release. The Company undertakes no obligation to update or revise these statements, whether as a result of new information, future developments, or otherwise, except as required by law.
About Sharps Technology
Sharps Technology is a medical device sales and distribution company that has adopted a digital asset treasury strategy focused on SOL, the native digital asset of the Solana blockchain. The Company is growing the Solana ecosystem through staking, validator infrastructure, and strategic collaborations. For additional information, please visit the Company’s website.
Contact
Sharps Technology IR
ir@sharpstechnology.com
